Intralesional steroid in the era of propranolol for infantile hemangioma—Do we need it?

Anand Pandey,Anurag Srivastava,Nitin Pant,Sudhir Singh,Jiledar Rawat

Journal of Plastic, Reconstructive & Aesthetic Surgery（2023）

引用 0|浏览4

暂无评分

摘要

Propranolol will be used as a first-line drug for IH. All superficial IHs are likely to respond. There will be a possibility of non-responding mixed or deep IH. Use of IL TMC seems reasonable for IH not responding to propranolol.

查看译文

关键词

Infantile hemangioma,Propranolol,Intralesional triamcinolone,Treatment failure

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要